Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital of Cologne

About this trial

This investigator-initiated, multicenter, international, retrospective registry aims to investigate outcomes of patients with atrial functional mitral regurgitation, as treated in clinical routine.

Eligibility criteria

Qualifiers

functional mitral regurgitation

left ventricular ejection fraction ≥50%

Disqualifiers

age under 18 years

known regional wall movement disorders

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 3 trial groups

Locations

22
Canada
St. Michael's Hospital Toronto Canada
France
Bordeaux University Hospital Bordeaux France
University Hospital Center of Nantes Nantes France
Germany
LMU Klinikum81377, MunichBavaria, Germany

Sponsors and collaborators

University Hospital of Cologne

Lead sponsor